Clinical TrialsSearch results
Number of results: 2568
No Longer Recruiting
- Phase 1 First Time in Human (FTIH), Open Label Study of GSK3745417 Administered to Participants With Advanced Solid Tumors
- advanced solid tumors
- Ishibashi Hideyasu
- 2022-05-19
No Longer Recruiting
- Phase 3, Open-label, Single-dose, Study of AAV5-hFIXco-Padua, CSL222, in Japanese Adult Male Subjects with Severe or Moderately Severe Hemophilia B
- Hemophilia B
- Akama Hideto
- 2023-07-29
No Longer Recruiting
- Phase I study to evaluate the safety of TDM-812 intra-tumor administration targeted for refractory breast cancer
- Breast cancer
- Kitano Atsuko
- 2020-06-22
No Longer Recruiting
- Phase II study of high-dose thoracic 3D-conformal radiotherapy without elective nodal irradiation concurrently combined with cisplatin and vinorelbine chemotherapy in patients with inoperable stage III non-small cell lung cancer
- inoperable stage III non-small cell lung cancer
- National Cancer Center Hospital
- 2009-03-02
No Longer Recruiting
- Post-marketing surveillance of LUTATHERA Injection (All Case Study)
- Somatostatin receptor-positive neuroendocrine tumors
- Maki Keiji
- 2022-05-17
No Longer Recruiting
- Safety, Tolerability, PK, PD, and Efficacy of AMG 427 in Subjects With Relapsed/Refractory Acute Myeloid Leukemia
- Relapsed/Refractory Acute Myeloid Leukemia (AML)
- Local Contact
- 2021-06-15
No Longer Recruiting
- Stentless mitral valve replacement using autologous pericardium study
- Mitral regurgitation
- Shimokawa Tomoki
- 2019-01-17
No Longer Recruiting
- Study of AMG 910 in Subjects With CLDN18.2-Positive Gastric and Gastroesophageal Junction Adenocarcinoma
- Gastric and Gastroesophageal Junction Adenocarcinoma
- Shimonaga Masahiro
- 2021-08-13
No Longer Recruiting
- Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors
- advanced or metastatic BC, prostate cancer or other solid tumor
- Kawai Norisuke
- 2023-06-07
No Longer Recruiting
- Survey of the Moderna COVID-19 Vaccine in People at High-Risk of developing Severe COVID-19 Symptoms
- Prevention of infectious disease caused by SARS-CoV-2
- Contact for Clinical Trial Information
- 2021-05-18